High dose inhaled fluticasone propionate and the hypothalamic-pituitary-adrenal axis in asthmatic patients with severe airflow obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 261s Year: 2004
Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
A low-dose (1.0 mcg) rapid ACTH test and adrenal function in adult patients with bronchial asthma treated with inhaled corticosteroids Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007
Anti-inflammatory effect of montelukast (ML) and inhaled steroids (ICS) on clinical parameters and serum levels of NO in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003
Mometasone furoate reduces oral corticosteroid requirements and permits recovery of hypothalamic-pituitary-adrenal axis function in patients with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
Adrenal function with low acth doses in asthmatic children with inhaled corticosteroids Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Assessment of baseline adrenal function by measurement of long term cortisol levels in scalp hair of asthmatic children using inhaled corticosteroids compared to healthy controls Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children Source: Eur Respir J 2006; 27: 316-320 Year: 2006
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma Source: Eur Respir J 2009; 33: 1277-1286 Year: 2009
Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Inhaled corticosteroid (ICS) induced metabolome changes in asthmatics. Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases Year: 2020
Adrenal function improvement of most asthmatic children on inhaled corticosteroids Source: Eur Respir J 2006; 28: Suppl. 50, 260s Year: 2006
Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol Source: International Congress 2019 – Airway physiology Year: 2019
Inhaled ciclesonide does not affect lower-leg growth rate or HPA-axis function in children with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 377s Year: 2004
Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response to low-dose ACTH test Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Screening for hypothalamic-pituitary-adrenal axis suppression (HPAS) in asthmatic children is not possible when employing clinical and static biochemical parameters Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Utility of salivary cortisol in corticotropin releasing hormone (CRH) test in asthmatics Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Is the combination of long-acting β2 -agonists (LABA) and inhaled steroids (ICS) superior to higher ICS dose in children and adults with persistent asthma? Source: Eur Respir J 2005; 26: Suppl. 49, 124s Year: 2005
Serum and urine eosinophil markers in children and adolescents with asthma treated with once or twice daily inhaled glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 449s Year: 2001